Eisler Capital (Uk) Ltd. Biogen Inc. Put Options Transaction History

Eisler Capital (Uk) Ltd.

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $1.98 Million - $2.46 Million	10,400 New	10,400 $2.41 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $7.5 Million - $9.03 Million	-33,700 Reduced 67.0%	16,600 $4.3 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $2.33 Million - $2.63 Million	9,200 Added 22.38%	50,300 $12.9 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $11.3 Million - $13.1 Million	41,100 New	41,100 $11.7 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $9.38 Million - $11.2 Million	-50,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $9.69 Million - $12.2 Million	50,000 New	50,000 $10.5 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.